CELEX:62020TA0248: Case T-248/20: Judgment of the General Court of 10 November 2021 — Stada Arzneimittel v EUIPO — Pfizer (RUXYMLA) (EU trade mark — Opposition proceedings — Application for the EU word mark RUXYMLA — Earlier EU word mark RUXIMERA — Relative ground for refusal — Likelihood of confusion — Similarity of the signs — Article 8(1)(b) of Regulation (EU) 2017/1001)

You are here:
Go to Top